BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 7565743)

  • 1. Core promoter specificities of the Sp1 and VP16 transcriptional activation domains.
    Emami KH; Navarre WW; Smale ST
    Mol Cell Biol; 1995 Nov; 15(11):5906-16. PubMed ID: 7565743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two leaky-late HSV-1 promoters differ significantly in structural architecture.
    Lieu PT; Wagner EK
    Virology; 2000 Jun; 272(1):191-203. PubMed ID: 10873762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of a heterologous promoter by human immunodeficiency virus type 1 Tat requires Sp1 and is distinct from the mode of activation by acidic transcriptional activators.
    Kamine J; Subramanian T; Chinnadurai G
    J Virol; 1993 Nov; 67(11):6828-34. PubMed ID: 8411386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of synergy between TATA and initiator: synergistic binding of TFIID following a putative TFIIA-induced isomerization.
    Emami KH; Jain A; Smale ST
    Genes Dev; 1997 Nov; 11(22):3007-19. PubMed ID: 9367983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of the initiator over the TATA box in human and yeast genes and identification of DNA motifs enriched in human TATA-less core promoters.
    Yang C; Bolotin E; Jiang T; Sladek FM; Martinez E
    Gene; 2007 Mar; 389(1):52-65. PubMed ID: 17123746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct recognition of initiator elements by a component of the transcription factor IID complex.
    Kaufmann J; Smale ST
    Genes Dev; 1994 Apr; 8(7):821-9. PubMed ID: 7926770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sp1 and AP2 regulate but do not constitute TATA-less human TAF(II)55 core promoter activity.
    Zhou T; Chiang CM
    Nucleic Acids Res; 2002 Oct; 30(19):4145-57. PubMed ID: 12364593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of sINR, a strict version of the Initiator core promoter element.
    Yarden G; Elfakess R; Gazit K; Dikstein R
    Nucleic Acids Res; 2009 Jul; 37(13):4234-46. PubMed ID: 19443449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of transcription from TATA-less promoters: identification of a new core promoter element XCPE2 and analysis of factor requirements.
    Anish R; Hossain MB; Jacobson RH; Takada S
    PLoS One; 2009; 4(4):e5103. PubMed ID: 19337366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cooperation between core promoter elements influences transcriptional activity in vivo.
    Colgan J; Manley JL
    Proc Natl Acad Sci U S A; 1995 Mar; 92(6):1955-9. PubMed ID: 7892207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional activation by Sp1 as directed through TATA or initiator: specific requirement for mammalian transcription factor IID.
    Smale ST; Schmidt MC; Berk AJ; Baltimore D
    Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4509-13. PubMed ID: 2141169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Requirements for activation of the herpes simplex virus glycoprotein C promoter in vitro by the viral regulatory protein ICP4.
    Gu B; DeLuca N
    J Virol; 1994 Dec; 68(12):7953-65. PubMed ID: 7966586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Properties of initiator-associated transcription mediated by GAL4-VP16.
    Chang C; Gralla JD
    Mol Cell Biol; 1993 Dec; 13(12):7469-75. PubMed ID: 8246964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cooperativity in vivo between the E2 transactivator and the TATA box binding protein depends on core promoter structure.
    Ham J; Steger G; Yaniv M
    EMBO J; 1994 Jan; 13(1):147-57. PubMed ID: 8306958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human immunodeficiency virus type 1 Vpr transactivator: cooperation with promoter-bound activator domains and binding to TFIIB.
    Agostini I; Navarro JM; Rey F; Bouhamdan M; Spire B; Vigne R; Sire J
    J Mol Biol; 1996 Sep; 261(5):599-606. PubMed ID: 8800208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional activation by herpes simplex virus type 1 VP16 in vitro and its inhibition by oligopeptides.
    Wu TJ; Monokian G; Mark DF; Wobbe CR
    Mol Cell Biol; 1994 May; 14(5):3484-93. PubMed ID: 8164693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation functions of transcription factor Sp1 at U2 snRNA and TATA box promoters.
    Forsberg M; Ström AC; Lillhager P; Westin G
    Biol Chem Hoppe Seyler; 1995 Nov; 376(11):661-9. PubMed ID: 8962675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TFII is required for transcription of the naturally TATA-less but initiator-containing Vbeta promoter.
    Manzano-Winkler B; Novina CD; Roy AL
    J Biol Chem; 1996 May; 271(20):12076-81. PubMed ID: 8662630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional activation by simian virus 40 large T antigen: requirements for simple promoter structures containing either TATA or initiator elements with variable upstream factor binding sites.
    Gilinger G; Alwine JC
    J Virol; 1993 Nov; 67(11):6682-8. PubMed ID: 8411370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Core promoter-specific gene regulation: TATA box selectivity and Initiator-dependent bi-directionality of serum response factor-activated transcription.
    Xu M; Gonzalez-Hurtado E; Martinez E
    Biochim Biophys Acta; 2016 Apr; 1859(4):553-63. PubMed ID: 26824723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.